★★★★☆
3.0 étoiles sur 5 de 589 commentaires client
Drug Discovery and Development: Technology in Transition - de (Broché - Sep 4, 2012) (Author)
Details Drug Discovery and Development: Technology in Transition
Le paragraphe ci-dessous contient les informations complètes concernant Drug Discovery and Development: Technology in Transition
| Le Titre Du Fichier | Drug Discovery and Development: Technology in Transition |
| Date de publication | |
| Traducteur | Sampson Kyria |
| Chiffre de Pages | 511 Pages |
| Taille du fichier | 52.21 MB |
| Langage | Anglais et Français |
| Éditeur | World Publishing Company |
| ISBN-10 | 1801810122-ZNL |
| Type de eBook | AMZ EPub PDF ABW PAGES |
| Écrivain | (Broché - Sep 4, 2012) |
| ISBN-13 | 706-9295486867-CXP |
| Nom de Fichier | Drug-Discovery-and-Development-Technology-in-Transition.pdf |
Télécharger Drug Discovery and Development: Technology in Transition Livre PDF Gratuit
Digital technology helps pharmaceutical manufacturing companies operate more efficiently and sustainably while accelerating healthcare innovation
À propos Drug Discovery Development serves the pharmaceutical biopharmaceutical and biotechnology industries contract research organizations government laboratories universities hospitals and medical centers and other industries within the life science marketplace
Rigel Pharmaceuticals South San Francisco 1 090 J’aime · 16 personnes étaient ici Rigel Pharmaceuticals Inc is a biotechnology company dedicated
Drug Discovery An Innovative Approach to Application Integration using SOA Ontology La SOA a profondément modifié le paysage de lintégration des applications Toutefois la nécessité de disposer dune recherche contextuelle et dune capacité de service demeure un défi
drug discovery challenges and implications “ The strategic application of a variety and combination of early in silico in vitro and in vivo animal studies heralds the possibility and opportunity for transforming the success and productivity of drug discovery and development
Life Technologies was acquired by Thermo Fisher Scientific in January 2014 Our innovative life science applied science and clinical products are now found under the Applied Biosystems™ Invitrogen™ Gibco™ Ion Torrent™ and Molecular Probes™ brands
The aim of this symposium will be to address the current trends in Immunotherapies discovery development from academic industrial and regulatory affairs point of view It will also allow to depict how collaborative research organizations can bring their added values altogether